On 3/26/24, Enanta Pharmaceuticals Inc (NASDAQ: ENTA) stock enjoyed a major increase of 14.4%, closing at $15.95. Moreover, this advance was accompanied by unusually high trading volume at 194% of normal. Relative to the market the stock has been weak over the last nine months but has risen 18.1% during the last week.
Current PriceTarget Research Rating
ENTA is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Enanta Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Enanta Pharmaceuticals has a very low Appreciation Score of 14 and a very low Power Rating of 5, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment